Vanguard Personalized Indexing Management
WST icon

Vanguard Personalized Indexing Management’s West Pharmaceutical WST Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.92M Buy
10,910
+897
+9% +$274K 0.03% 411
2026
Q1 		$2.51M Sell
10,013
-1,227
-11% -$305K 0.02% 526
2025
Q4 		$3.09M Buy
11,240
+16
+0.1% +$4.38K 0.03% 450
2025
Q3 		$2.94M Buy
11,224
+1,322
+13% +$321K 0.03% 453
2025
Q2 		$2.17M Buy
9,902
+1,804
+22% +$386K 0.02% 542
2025
Q1 		$1.81M Sell
8,098
-2,734
-25% -$753K 0.03% 525
2024
Q4 		$3.55M Buy
10,832
+2,906
+37% +$915K 0.05% 310
2024
Q3 		$2.38M Sell
7,926
-3,876
-33% -$1.19M 0.04% 415
2024
Q2 		$3.86M Sell
11,802
-114
-1% -$40.3K 0.07% 234
2024
Q1 		$4.72M Buy
11,916
+278
+2% +$103K 0.1% 181
2023
Q4 		$4.1M Buy
11,638
+698
+6% +$247K 0.11% 174
2023
Q3 		$4.1M Buy
10,940
+657
+6% +$254K 0.12% 146
2023
Q2 		$3.93M Buy
10,283
+320
+3% +$114K 0.12% 148
2023
Q1 		$3.45M Buy
9,963
+1,058
+12% +$309K 0.12% 159
2022
Q4 		$2.1M Buy
8,905
+537
+6% +$127K 0.09% 253
2022
Q3 		$2.06M Sell
8,368
-68
-0.8% -$20.7K 0.09% 219
2022
Q2 		$2.55M Buy
8,436
+632
+8% +$206K 0.12% 164
2022
Q1 		$3.21M Buy
7,804
+1,091
+16% +$427K 0.16% 110
2021
Q4 		$3.15M Buy
6,713
+5,119
+321% +$2.2M 0.19% 96
2021
Q3 		$677K Buy
1,594
+317
+25% +$134K 0.06% 366
2021
Q2 		$459K Buy
1,277
+481
+60% +$159K 0.05% 524
2021
Q1 		$224K Buy
796
+61
+8% +$17.5K 0.03% 631
2020
Q4 		$208K Buy
+735
New +$206K 0.05% 497

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Personalized Indexing Management's WST Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its West Pharmaceutical (WST) stake by 9% in Q2 2026, buying an estimated $274K and bringing the position to 10,910 shares worth $3.92M. The position accounts for 0.03% of the portfolio, ranked #411.

Vanguard Personalized Indexing Management first reported a position in WST in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.72M in Q1 2024. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Vanguard Personalized Indexing Management held 10,910 shares of West Pharmaceutical worth $3.92M as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 897 West Pharmaceutical shares in Q2 2026, an estimated $274K.
  • West Pharmaceutical made up 0.03% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #411 holding.
  • Vanguard Personalized Indexing Management first reported a position in West Pharmaceutical in Q4 2020 and has held it in 23 quarters since.
  • Vanguard Personalized Indexing Management's West Pharmaceutical position peaked at $4.72M in Q1 2024.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.